A traditional model for developing a biotechnology Company is in short first to raise money from a VC firm to obtain funding for R&D activities. This importantly also helps to brand the Company/management as a good Investment. Later can co-development deals with big-pharma Companies further augment the intrinsic value of your company towards a successful exit anywhere along the line. It is naturally easier to raise money when the technology works and on the back of outstanding scientific accomplishments and new IP towards this exit, but what are the success factors that make your company attractive for successive rounds of VC investments, big-pharma partnerships and finally will allow you and your investors to make a successful exit? And how can you ensure to include these X-factors in your company activities? And what should the price of your ideas and data be?



  • X-FACTORSWhat are the X-factors to secure sustained growth? Waht does your invention need to deliver etc.?
  • CASH, TIME & RISKSWhat does it actually cost to bring a new therapeutic solution to the market? How long does it take? And what are the risks associated with the discovery/development activities?
  • VALUATIONValuation of R&D projects for raising funds, out-licencing activities etc. are no trivial task. Short introduction into available methodologies with description of current industry standards.
  • BD FOR BIOTECH & PHARMAWhere to find relevant information´s with respect to your business development activities? List of what we believe are valuable databases.
  • CRO´s (~650) IN BIOBUSINESSThe biotech business models often includes a virtual/semi-virtual R&D setting with limited investments in fixed assets and outsourcing of all/selected R&D activities to CRO´s. Use our searchable list of CRO´s in the biobusiness world-wide to identify potential partners.
  • FRESH MONEYWhere can you go to raise funds? Venture Capitalists are the traditional source of risk capital to the biotech marketplace. Non-dilutive funding options should not be overlooked for (supplements to) funding your biobusiness.
  • THE TERM SHEET – The price of growth. Who gets what and on what terms? An essential element of dealing with VC´s is the elements included in the term-sheets.
  • VC FIRM STRUCTUREWhere do VC´s get their money from? Who should you address in a VC Company? And how does the VC firm structure affects you as an entrepreneur?
  • VC FIRM LISTVenture Capitalist funding is often the single available option for funding your biobusiness. Use our searchable list of >200 VC firms active in the biobusiness arena world-wide to find potential VC partners in your zone of business activities.
  • FOUNDER SHARESGet it right from the start – suggestions for starting your high-tech Company with respect to vesting of the founder share equity pool.

Print Friendly